The focus of hepatocellular carcinoma (HCC) research for many years has been on
noninvasive diagnosis. Standardized systematic algorithms composed of combinations of …

Intrahepatic cholangiocarcinoma (iCCA) is an aggressive primary liver malignancy with an
increasing incidence worldwide. Recently, histopathologic classification of small duct type …

Cholangiocarcinomas (CCA) are a heterogeneous group of tumors that are classified as
intrahepatic, perihilar, or distal according to the anatomic location within the biliary tract …

Objectives Contrast-enhanced MRI can provide individualized prognostic information for
hepatocellular carcinoma (HCC). We aimed to investigate the value of MRI features to …

Simple Summary Intrahepatic cholangiocarcinoma is the second most common primary liver
malignancy after hepatocellular carcinoma and accounts for 20% of biliary tract cancers. The …

Context.—Cholangiocarcinoma (CCA) is a heterogeneous cancer of the bile duct, and its
diagnosis is often challenging. Objective.—To provide insights into state-of-the-art …

Most of the organs of the digestive tract comprise secretory epithelia that require specialized
molecular machines to achieve their functions. As such anterior gradient (AGR) proteins …

Simple Summary Cholangiocarcinoma (CCA) is a chemotherapy-resistant cancer.
Reportedly, combination chemotherapy that includes immune checkpoint inhibitors (ICIs) …

Hepatocellular carcinoma (HCC) is the fourth most lethal malignancy with an increasing
incidence worldwide. Management of HCC has followed several clinical staging systems …

Objective Selecting interventions for patients with solitary hepatocellular carcinoma (HCC)
remains a challenge. Despite gross classification being proposed as a potential prognostic …